Savant Capital LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,974 shares of the healthcare conglomerate’s stock after buying an additional 294 shares during the period. Savant Capital LLC’s holdings in UnitedHealth Group were worth $816,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in UNH. Harris Associates L P raised its position in UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after buying an additional 14,489 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in shares of UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock valued at $717,199,000 after buying an additional 255,799 shares in the last quarter. American Century Companies Inc. raised its position in shares of UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock valued at $659,649,000 after buying an additional 333,338 shares in the last quarter. Swiss National Bank raised its position in shares of UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares in the last quarter. 86.21% of the stock is owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.37% on Monday, reaching $191.53. 347,170 shares of the company’s stock traded hands. The company has a 50 day moving average of $190.49 and a 200-day moving average of $175.87. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04. The stock has a market capitalization of $185.18 billion, a PE ratio of 23.01 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.96 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.57%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s payout ratio is currently 35.13%.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/08/21/savant-capital-llc-increases-position-in-unitedhealth-group-incorporated-unh.html.

UNH has been the topic of several recent analyst reports. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. Cantor Fitzgerald restated an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a report on Friday, July 21st. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective on the stock in a report on Tuesday, May 30th. CIBC upped their price objective on shares of UnitedHealth Group from $186.00 to $187.00 and gave the stock an “outperform” rating in a report on Monday, April 24th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a report on Friday, May 19th. One investment analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $203.41.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock valued at $2,873,320 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.